期刊文献+

贝那普利联合氨氯地平治疗高血压患者的疗效及对血压变异性的影响

下载PDF
导出
摘要 目的探讨贝那普利联合氨氯地平治疗高血压患者的疗效及对血压变异性的影响。方法选取2016年9月至2017年7月治疗的106例高血压患者为研究对象,按照随机数字表法将其分为试验组和对照组,各53例。对照组给予氨氯地平治疗,试验组在对照组治疗基础上联合贝那普利治疗,比较两组治疗效果、血压变异性及不良反应。结果试验组治疗总有效率96.23%,明显高于对照组81.13%,差异有统计学意义(P<0.05);治疗后,两组血压及血压变异性低于治疗前,治疗后试验组血压及血压变异性低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论贝那普利联合氨氯地平治疗高血压患者疗效显著,可控制患者血压及血压变异性,有利于患者康复治疗,且用药安全可靠。
作者 耿关富
出处 《医疗装备》 2018年第14期88-89,共2页 Medical Equipment
  • 相关文献

参考文献5

二级参考文献52

  • 1Pool J, Kaihlanen P, Lewis G, et al. 1Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and be- nazepril vs amlodipine or benazepril alone [J]. J Hum Hypertens, 2011, 15(7): 4951.
  • 2Blackburn DF, Wilson TW. Antihypertensive medications and blood sugar: theories and implications [J]. Can J Cardiol, 2006, 22 (3): 229-233.
  • 3Amlan Kanti Sarkar, Debotri Ghosh, Ayan Das, et al. Simultaneous determination of metoprolol succinate and amlodipine besylate in hu- man serum by liquid chromatography-tandem mass spectrometry method and its application in bioequivalence study [J]. Journal of Chromatography B, 2008, 873(1): 77-85.
  • 4Sarkar AK, Ghosh D, Das A, et al. Simultaneous determination of metoprolol succinate and amlodipine besylate in human plasma by liquid chromatography-tandem mass spectrometry method and its ap- plication in bioequivalence study [J]. J Chromatogr B, 2008, 873(1): 77-85.
  • 5Chohar ian AV, Bakris GL, Black Hr, et al. The seventh report of the joint national Committee on prevention. D.etetion evaluation, and treatment of high blood pressure[J]. JAMA, 2003, 289:3560-3566.
  • 6Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodip- ine or hydroch-lorothiazide for hypertension in high-risk patients [J]. N Eng J Med, 2008, 359(23): 2417-2428.
  • 7Inaba S, Iwai M, Tomono Y, et al. Prevention of vascular injury by combination of an AT1 receptor blocker, olmesartan, with various calcium antagonists[J]. Am J Hypertens, 2009, 22(2): 145-150.
  • 8Chen S, Evans T, Deng D, et al. Hyperhexosemia induced function- al and structural changes in the kidneys : role of endothelins [ J ]. Nephron ,2002,90( 1 ) :86-94.
  • 9Chalmers J, Macmahon S, Mancia G, et al. 1999 World Health Or- ganization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization [ J ]. Clin Exp Hypertenz, 1999,21 ( 5/ 6 ) : 1009-1060.
  • 10Mackinnon M, Shurraw S, Akbari A ,et al. Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data [J] Am J Kidney Dis ,2006,48( 1 ) :8-20.

共引文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部